Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

Terminated

• Conditions: Congenital Heart Disease
• Interventions: Other: Blood draws

• Registration Number: NCT00850720
• Lead Sponsor: Emory University

Brief Summary

The goal of this study is to evaluate specific hormone levels in children undergoing heart surgery in order to identify patterns associated with any unstable vital signs. The data collected will provide preliminary answers to the question "Are hormone values a determining factor for drug administration and dosing levels?" and help establish the benefits of routine steroid and hormone administration. Sixty subjects will be enrolled. Blood samples will be drawn before the surgery,and again nine hours after surgery for analysis. Other patient data such as medications, vital signs, routine lab values and treatments will also be analyzed. As our current standard of care includes routine doses of steroids, we believe this study will increase our general knowledge and improve the care of these critically ill children. The study will also provide the foundation needed for grant support from the American Heart Association, allowing for future larger scale studies.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2009-02-24
• Study First Submitted QC: 2009-02-24
• Study First Posted: 2009-02-25
• Study Start: 2009-03
• Primary Completion: 2009-10
• Study Completion: 2009-10
• Results First Submitted: 2010-01-15
• Status Verified: 2013-11
• Results First Submitted QC: 2013-11-18
• Last Update Submitted: 2013-11-18
• Results First Posted: 2014-01-07
• Last Update Posted: 2014-01-07

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

• Children with congenital heart disease requiring cardiopulmonary bypass(CPB) surgery less than 1 year of age admitted to the cardiac intensive care unit (CICU) preoperatively, who required blood sampling as part of their care.
• Subject must have arterial or central venous lines to be enrolled.
• Subject must have a documented weight of 2.5 Kilograms or greater.
• Subjects' legal guardian shall possess the ability to understand the purposes and risks of the study and provide an informed consent signature.

Read More

Exclusion Criteria

• Medical urgency preventing timely administration of the consenting process.
• Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating. Specific conditions might include, but are not limited to, anemia or coagulopathy.
• Have given steroids intravenously (IV) or oral steroids within the last month.
• Have a preexisting neuroendocrine disorder.
• Have been treated with antipsychotic medication.
• Have human immunodeficiency virus (HIV).
• Have received etomidate for intubation.
• Other technical considerations that would prevent acquisition of sufficient samples OR inability / unwillingness of the legal guardian to provide consent.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cardiac Surgery	Blood draws	Infants with congenital defects.

Primary Outcome Measures

Name	Time	Method
NO Outcomes - Study Terminated Without Data.	Study terminated - no data.

Trial Locations

Locations (1)

Children's Healthcare of Atlanta at Egleston; 🇺🇸 Atlanta, Georgia, United States